Reply to: Ahren B et al. Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans. Diabetes Obes Metab 2011; 13(9): 775–783 and Ahren B et al. Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin. Diabetes Obes Metab 2011; 13(3): 193–203

✍ Scribed by R. D. Carr; H. L. Katzeff; C. M. Alexander; J. P. Berger; S. S. Xu; N. Thornberry

• Book ID: 115185019
• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 443 KB
• Volume: 14
• Category: Article
• ISSN: 1462-8902
• DOI: 10.1111/j.1463-1326.2011.01542.x